Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax to Move Forward With Covid-19-Flu Vaccine
Here's when to get vaccinated for best protection against COVID, flu, RSV for holidays
The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your vaccinations by to be best protected.
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S. Food and Drug Administration had removed the clinical hold on its investigational new drug application for its combined vaccine and its standalone flu vaccine candidates.
Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold
Key Takeaways Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.Regulators stopped testing last month as one patient had a serious adverse event after taking the shot.
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination vaccine candidates.
16h
No, Japan didn’t name COVID-19 vaccine ‘most deadly drug in history’ | Fact check
There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.
1h
Devout Catholic worker fired for not getting COVID shot wins over $12M in religious discrimination suit
A devout Catholic was awarded nearly $13 million in a discrimination lawsuit claiming she was fired in 2022 for refusing to ...
18h
on MSN
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of ...
1d
Idaho health agency halts COVID vaccine program, joining backlash
Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back ...
1d
on MSN
Catholic woman fired for refusing COVID vaccine wins over $12M in Michigan court
A woman who was fired for refusing to comply with her employer's COVID-19 mandate due to her Catholic faith was awarded over ...
The Harvard Crimson
53m
Former Instructor Sues HMS, Alleges Wrongful Termination for Refusing Covid-19 Vaccine
A former Harvard Medical School instructor filed a lawsuit against Harvard last week, alleging he was wrongfully terminated by HMS because he requested an exception to the Covid-19 vaccine mandate.
2d
on MSN
Woman Fired For Refusing Covid Vaccine Wins Record $12 Million
A former Blue Cross Blue Shield of Michigan employee was terminated after declining to get a vaccination in 2021 wins big.
13wham
16h
Catholic woman fired for refusing COVID vaccine awarded nearly $13M by Michigan court
WASHINGTON (TNND) — A Catholic woman who was fired for refusing the
COVID
-19
vaccine
was awarded over $12 million by a ...
5d
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
Crain's Detroit
1d
Jury rebukes Blue Cross COVID vaccine mandate in $12.7M verdict for fired employee
A person enrolled in a clinical trial receives the COVID vaccine. Employers' vaccine mandates came under scrutiny during the ...
6h
Harvard Medical Teacher Says He Was Axed for Vaccine Refusal (1)
A long-time Harvard Medical School instructor of psychiatry claims his appointment was wrongfully terminated after he was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Novavax
Donald Trump
United States
Moderna
Lisa Domski
Feedback